FDA 483 - Chifeng Pharmaceutical Company, Ltd. - October 13, 2017
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Chifeng Pharmaceutical Co., Ltd. in Chifeng, P.R. China, an Active Pharmaceutical Ingredient Manufacturer, received a Form 483 with nine observations. The inspection revealed significant issues across contamination control, material management, deviation documentation, equipment qualification, record-keeping, quality reviews, software validation, and pest control. These findings indicate a broad lack of adherence to good manufacturing practices, posing potential risks to product quality and integrity.
ID · deee763a-484f-4fbf-b5b0-fddb433b6a3d